Similar articles

• Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.

  McIntosh PB, Frenkiel TA, Wollborn U, McCormick JE, Klempnauer KH, Feeney J, Carr MD. McIntosh PB, et al. Biochemistry. 1998 Jul 7;37(27):9619-29. doi: 10.1021/bi972861z. Biochemistry. 1998. PMID: 9657674
• Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: implications for sequence-specific DNA binding by Myb proteins.

  Carr MD, Wollborn U, McIntosh PB, Frenkiel TA, McCormick JE, Bauer CJ, Klempnauer KH, Feeney J. Carr MD, et al. Eur J Biochem. 1996 Feb 1;235(3):721-35. doi: 10.1111/j.1432-1033.1996.00721.x. Eur J Biochem. 1996. PMID: 8654422
• Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.

  Bessa M, Saville MK, Watson RJ. Bessa M, et al. Oncogene. 2001 Jun 7;20(26):3376-86. doi: 10.1038/sj.onc.1204439. Oncogene. 2001. PMID: 11423988
• STATs: signal transducers and activators of transcription.

  Ihle JN. Ihle JN. Cell. 1996 Feb 9;84(3):331-4. doi: 10.1016/s0092-8674(00)81277-5. Cell. 1996. PMID: 8608586 Review. No abstract available.
• B-Myb: a key regulator of the cell cycle.

  Saville MK, Watson RJ. Saville MK, et al. Adv Cancer Res. 1998;72:109-40. doi: 10.1016/s0065-230x(08)60701-0. Adv Cancer Res. 1998. PMID: 9338075 Review. No abstract available.